A high triglyceride-glucose index associated with adverse cardiovascular events in patients with type 2 diabetes mellitus and chronic total occlusion after percutaneous coronary intervention

被引:8
|
作者
Lin, Xiao Long [1 ,2 ]
Li, Qiu Yu [1 ,2 ]
Zhao, Dong Hui [1 ,2 ]
Liu, Jing Hua [1 ,2 ]
Fan, Qian [1 ,2 ,3 ,4 ]
机构
[1] Capital Med Univ, Beijing AnZhen Hosp, Ctr Coronary Artery Dis, Beijing, Peoples R China
[2] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China
[3] Capital Med Univ, Beijing AnZhen Hosp, Ctr Coronary Artery Dis, Beijing 100029, Peoples R China
[4] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
关键词
Triglyceride-glucose index; type 2 diabetes mellitus; chronic total occlusion; percutaneous coronary intervention; adverse cardiovascular outcomes; HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; CLINICAL-OUTCOMES; IMPACT; REVASCULARIZATION; SURROGATE; PRODUCT; RISK; CELL;
D O I
10.1177/10815589231152823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Triglyceride-glucose index (TyG index) is a reliable surrogate marker of insulin resistance, associated with morbidity and prognosis of cardiovascular disease. However, its predictive value for cardiovascular events in patients with type 2 diabetes mellitus (T2DM) and chronic total occlusion (CTO) after percutaneous coronary intervention (PCI) has not been studied. Here, we retrospectively enrolled 681 patients with T2DM and CTO after PCI. Patients were divided into two groups based on a median TyG index of 9.02. The TyG index was calculated as ln [fasting triglyceride (mg/dL) x fasting glucose (mg/dL)/2]. The primary observational end point was the composite of overall death, nonfatal myocardial infarction, and unplanned revascularization. The Multivariate Cox hazards regression analysis showed that the TyG index was significantly correlated with the primary end point (hazard ratio = 1.699, 95% confidence interval 1.254-2.303, p = 0.001). The addition of TyG to a baseline risk model had an incremental effect on the predictive value for the primary end point (area under the curve: TyG index vs baseline model, 0.693 vs 0.663, comparison p = 0.040; integrated discrimination improvement = 0.049, p = 0.020). The TyG index might be a predictor of adverse cardiovascular events. Moreover, adding the TyG index into a baseline risk model had a cumulative effect on the predictive potential for the primary end point.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 50 条
  • [1] The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion
    Li, Yingkai
    He, Songyuan
    Wu, Zheng
    Li, Wenzheng
    Jian, Wen
    Cheng, Zichao
    Wang, Cong
    Shi, Yuchen
    Liu, Jinghua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [2] Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention
    Chen, Qiang
    Xiong, Shiqiang
    Zhang, Zhen
    Yu, Xiuqiong
    Chen, Yingzhong
    Ye, Tao
    Yang, Siqi
    Qi, Lingyao
    Chen, Xu
    Liu, Hanxiong
    Zheng, Jingang
    Cai, Lin
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [3] Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention
    Qiang Chen
    Shiqiang Xiong
    Zhen Zhang
    Xiuqiong Yu
    Yingzhong Chen
    Tao Ye
    Siqi Yang
    Lingyao Qi
    Xu Chen
    Hanxiong Liu
    Jingang Zheng
    Lin Cai
    Cardiovascular Diabetology, 22
  • [4] Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
    Ma, Xiaoteng
    Dong, Lisha
    Shao, Qiaoyu
    Cheng, Yujing
    Lv, Sai
    Sun, Yan
    Shen, Hua
    Wang, Zhijian
    Zhou, Yujie
    Liu, Xiaoli
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [5] Triglyceride-glucose index in the prediction of major adverse cardiovascular events in patients with type 2 diabetes mellitus after coronary artery bypass surgery: A retrospective cohort study
    Zhang, He
    Chong, Hoshun
    Li, Zeshi
    Li, Kai
    Zhang, Bomin
    Xue, Yunxing
    Wang, Dongjin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention
    Xiong, Shiqiang
    Chen, Qiang
    Zhang, Zhen
    Chen, Yingzhong
    Hou, Jun
    Cui, Caiyan
    Cheng, Lianchao
    Su, Hong
    Long, Yu
    Yang, Siqi
    Qi, Lingyao
    Chen, Xu
    Liu, Hanxiong
    Cai, Lin
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [7] Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
    Wang, Le
    Cong, Hong-liang
    Zhang, Jing-xia
    Hu, Yue-cheng
    Wei, Ao
    Zhang, Ying-yi
    Yang, Hua
    Ren, Li-bin
    Qi, Wei
    Li, Wen-yu
    Zhang, Rui
    Xu, Jing-han
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [8] Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes
    Tai, Shi
    Fu, Liyao
    Zhang, Ningjie
    Yang, Rukai
    Zhou, Yuying
    Xing, Zhenhua
    Wang, Yongjun
    Zhou, Shenghua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [9] Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
    Tao, Shiyi
    Yu, Lintong
    Li, Jun
    Xie, Zicong
    Huang, Li
    Yang, Deshuang
    Tan, Yuqing
    Zhang, Wenjie
    Huang, Xuanchun
    Xue, Tiantian
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [10] Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
    Xiaoteng Ma
    Lisha Dong
    Qiaoyu Shao
    Yujing Cheng
    Sai Lv
    Yan Sun
    Hua Shen
    Zhijian Wang
    Yujie Zhou
    Xiaoli Liu
    Cardiovascular Diabetology, 19